pharma · Idiopathic Pulmonary Fibrosis · Prevention of breast cancer in women with a BRCA1 germline mutation
Shanghai Zerun Biotechnology
Shanghai Reinovax Biologics Co.,LTD
Shanghai Zerun Biotechnology is a pharma organization headquartered in Shanghai, CN. Primary therapeutic focus areas include Idiopathic Pulmonary Fibrosis, Prevention of breast cancer in women with a BRCA1 germline mutat
936号 Zhangheng Rd, Shanghai 201203, CN HQ
21 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 936号 Zhangheng Rd, Shanghai 201203, CN
- Employees
- 21
- Programs
- 11
- Drugs
- 33
- Patents
- 11
LTI-03
Phase 1 · small molecule · Idiopathic Pulmonary Fibrosis
LTI-03 for Idiopathic Pulmonary Fibrosis is a Phase 1 program (small_molecule) at Shanghai Reinovax Biologics Co.,LTD with 1 ClinicalTrials.gov record(s).
Internal code LTI-03-1002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shanghai Reinovax Biologics Co.,LTD
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Idiopathic Pulmonary Fibrosis
- Status
- completed
- Trials
- 1